HomeCompareBMXMF vs MRK

BMXMF vs MRK: Dividend Comparison 2026

BMXMF yields 1.00% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMXMF wins by $4.56M in total portfolio value· pulled ahead in Year 5
10 years
BMXMF
BMXMF
● Live price
1.00%
Share price
$102.25
Annual div
$1.03
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.62M
Annual income
$3,874,899.32
Full BMXMF calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — BMXMF vs MRK

📍 BMXMF pulled ahead of the other in Year 5

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMXMFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMXMF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BMXMF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMXMF
Annual income on $10K today (after 15% tax)
$85.29/yr
After 10yr DRIP, annual income (after tax)
$3,293,664.42/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, BMXMF beats the other by $3,285,336.01/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMXMF + MRK for your $10,000?

BMXMF: 50%MRK: 50%
100% MRK50/50100% BMXMF
Portfolio after 10yr
$2.34M
Annual income
$1,942,348.73/yr
Blended yield
83.12%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

BMXMF
Analyst Ratings
4
Buy
1
Hold
Consensus: Buy
Altman Z
6.7
Piotroski
7/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMXMF buys
0
MRK buys
0
No recent congressional trades found for BMXMF or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMXMFMRK
Forward yield1.00%2.76%
Annual dividend / share$1.03$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$4.62M$56.8K
Annual income after 10y$3,874,899.32$9,798.13
Total dividends collected$4.53M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: BMXMF vs MRK ($10,000, DRIP)

YearBMXMF PortfolioBMXMF Income/yrMRK PortfolioMRK Income/yrGap
1$10,901$200.68$11,206$366.19$305.00MRK
2$12,073$408.90$12,650$502.35$577.00MRK
3$13,764$846.46$14,407$694.19$643.00MRK
4$16,532$1,803.86$16,585$967.82$53.00MRK
5← crossover$21,738$4,049.60$19,342$1,363.89+$2.4KBMXMF
6$33,213$9,953.40$22,913$1,947.19+$10.3KBMXMF
7$63,964$28,425.29$27,662$2,823.89+$36.3KBMXMF
8$170,764$102,322.42$34,159$4,173.35+$136.6KBMXMF
9$693,315$510,597.75$43,337$6,308.80+$650.0KBMXMF
10$4,616,746$3,874,899.32$56,776$9,798.13+$4.56MBMXMF

BMXMF vs MRK: Complete Analysis 2026

BMXMFStock

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems, which use biological samples to diagnose infectious diseases, cardiovascular pathologies, and various cancers; and microbiological testing of manufacturing primarily for food, pharmaceutical, cosmetics, and veterinary sectors. It serves clinical and hospital laboratories, physicians, blood banks, and industrial control laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is headquartered in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Full BMXMF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this BMXMF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMXMF vs SCHDBMXMF vs JEPIBMXMF vs OBMXMF vs KOBMXMF vs MAINBMXMF vs JNJBMXMF vs ABBVBMXMF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.